 Emily Gurnee
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urticaria Pigmentosa | 2 | 2020 | 2 | 1.260 |
Why?
| | Dermatitis, Atopic | 2 | 2026 | 322 | 1.260 |
Why?
| | Mastocytosis, Cutaneous | 2 | 2020 | 5 | 1.260 |
Why?
| | Mastocytosis | 2 | 2020 | 11 | 1.250 |
Why?
| | Dermatology | 4 | 2022 | 128 | 1.200 |
Why?
| | Food Hypersensitivity | 1 | 2026 | 164 | 0.800 |
Why?
| | Acne Vulgaris | 2 | 2022 | 25 | 0.760 |
Why?
| | Hemolysin Proteins | 1 | 2020 | 36 | 0.650 |
Why?
| | Staphylococcus | 1 | 2020 | 75 | 0.640 |
Why?
| | Bacterial Toxins | 1 | 2020 | 110 | 0.630 |
Why?
| | Mastocytosis, Systemic | 1 | 2019 | 7 | 0.600 |
Why?
| | Skin | 2 | 2020 | 758 | 0.570 |
Why?
| | Dermoscopy | 1 | 2018 | 11 | 0.560 |
Why?
| | Complementary Therapies | 1 | 2019 | 94 | 0.550 |
Why?
| | Anaphylaxis | 1 | 2019 | 102 | 0.540 |
Why?
| | Plant Extracts | 1 | 2019 | 187 | 0.520 |
Why?
| | Ecchymosis | 1 | 2017 | 3 | 0.510 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2026 | 1420 | 0.500 |
Why?
| | Caregivers | 1 | 2026 | 1056 | 0.500 |
Why?
| | Health Resources | 1 | 2018 | 131 | 0.500 |
Why?
| | Ciprofloxacin | 1 | 2015 | 26 | 0.450 |
Why?
| | Intimate Partner Violence | 1 | 2017 | 92 | 0.440 |
Why?
| | Dietary Supplements | 1 | 2019 | 576 | 0.440 |
Why?
| | Carrier State | 1 | 2015 | 79 | 0.420 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 129 | 0.420 |
Why?
| | Patient Preference | 1 | 2017 | 226 | 0.420 |
Why?
| | Bacterial Proteins | 1 | 2020 | 962 | 0.410 |
Why?
| | Feces | 2 | 2015 | 514 | 0.400 |
Why?
| | Enterococcus | 1 | 2013 | 22 | 0.400 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 199 | 0.400 |
Why?
| | Gastrointestinal Tract | 1 | 2015 | 208 | 0.370 |
Why?
| | Escherichia coli | 1 | 2015 | 855 | 0.320 |
Why?
| | Tryptases | 2 | 2020 | 13 | 0.320 |
Why?
| | Skin Diseases | 2 | 2024 | 149 | 0.310 |
Why?
| | Pediatrics | 1 | 2018 | 1118 | 0.300 |
Why?
| | Clinical Competence | 1 | 2018 | 1247 | 0.300 |
Why?
| | Child | 10 | 2026 | 22712 | 0.300 |
Why?
| | Child, Preschool | 8 | 2026 | 11863 | 0.290 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 461 | 0.290 |
Why?
| | Down Syndrome | 2 | 2024 | 534 | 0.260 |
Why?
| | Infant | 6 | 2026 | 10101 | 0.240 |
Why?
| | Severity of Illness Index | 2 | 2026 | 2926 | 0.230 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 28 | 0.210 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1922 | 0.210 |
Why?
| | Piperidines | 1 | 2024 | 218 | 0.190 |
Why?
| | Pyrimidines | 1 | 2024 | 533 | 0.170 |
Why?
| | Balsams | 1 | 2020 | 2 | 0.160 |
Why?
| | Telemedicine | 2 | 2022 | 957 | 0.160 |
Why?
| | Genital Diseases, Female | 1 | 2020 | 31 | 0.160 |
Why?
| | Humans | 15 | 2026 | 145307 | 0.160 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2020 | 73 | 0.150 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2019 | 17 | 0.150 |
Why?
| | Adolescent | 5 | 2024 | 22507 | 0.150 |
Why?
| | Hemolysis | 1 | 2020 | 243 | 0.140 |
Why?
| | Female | 9 | 2026 | 78605 | 0.140 |
Why?
| | Infant, Newborn | 3 | 2024 | 6456 | 0.140 |
Why?
| | Exanthema | 1 | 2019 | 84 | 0.140 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 94 | 0.140 |
Why?
| | Mast Cells | 1 | 2019 | 146 | 0.130 |
Why?
| | Mandatory Reporting | 1 | 2017 | 47 | 0.130 |
Why?
| | Teaching Rounds | 1 | 2018 | 74 | 0.120 |
Why?
| | Child Protective Services | 1 | 2017 | 64 | 0.120 |
Why?
| | Male | 7 | 2026 | 72629 | 0.120 |
Why?
| | Adult | 6 | 2024 | 40627 | 0.110 |
Why?
| | Molecular Typing | 1 | 2015 | 21 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2026 | 6079 | 0.110 |
Why?
| | Education, Medical | 1 | 2018 | 276 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2015 | 215 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2026 | 5883 | 0.100 |
Why?
| | Poverty | 1 | 2018 | 530 | 0.100 |
Why?
| | Vancomycin Resistance | 1 | 2013 | 16 | 0.100 |
Why?
| | Methicillin Resistance | 1 | 2013 | 17 | 0.100 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 560 | 0.100 |
Why?
| | Young Adult | 3 | 2024 | 14163 | 0.080 |
Why?
| | Genotype | 1 | 2015 | 1845 | 0.080 |
Why?
| | Prevalence | 1 | 2015 | 2838 | 0.070 |
Why?
| | United States | 3 | 2024 | 16051 | 0.060 |
Why?
| | Prospective Studies | 2 | 2022 | 8011 | 0.060 |
Why?
| | Internship and Residency | 1 | 2018 | 1261 | 0.060 |
Why?
| | Mothers | 1 | 2013 | 776 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2024 | 17149 | 0.060 |
Why?
| | International Classification of Diseases | 1 | 2024 | 147 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 218 | 0.050 |
Why?
| | Canada | 1 | 2024 | 429 | 0.050 |
Why?
| | Isotretinoin | 1 | 2022 | 26 | 0.040 |
Why?
| | Pregnancy | 1 | 2015 | 7208 | 0.040 |
Why?
| | Genitalia, Female | 1 | 2020 | 42 | 0.040 |
Why?
| | Administration, Topical | 1 | 2020 | 150 | 0.040 |
Why?
| | Drug Eruptions | 1 | 2019 | 28 | 0.040 |
Why?
| | Autoimmunity | 1 | 2024 | 935 | 0.040 |
Why?
| | Afghanistan | 1 | 2018 | 96 | 0.030 |
Why?
| | Fever | 1 | 2019 | 312 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2022 | 706 | 0.030 |
Why?
| | Internationality | 1 | 2018 | 156 | 0.030 |
Why?
| | Culturally Competent Care | 1 | 2018 | 74 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1510 | 0.030 |
Why?
| | Cytokines | 1 | 2024 | 2066 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1500 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1327 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1894 | 0.020 |
Why?
| | Curriculum | 1 | 2018 | 1072 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1196 | 0.020 |
Why?
| | Middle Aged | 1 | 2024 | 36021 | 0.010 |
Why?
|
|
Gurnee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|